MOLECULAR ALTERATIONS OF FACTOR VIII VON WILLEBRAND FACTOR (F-VIII-VWF) IN VON WILLEBRANDS DISEASE (VWD)

被引：0
|
作者：
GRALNICK, HR
COLLER, BS
SULTAN, Y
机构：
[1] NIH,BETHESDA,MD
[2] HOP ST LOUIS,PARIS,FRANCE
来源：
THROMBOSIS ET DIATHESIS HAEMORRHAGICA | 1975年 / 34卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：902 / 902
页数：1
相关论文
共 50 条
  • [31] Evaluation of a commercial von Willebrands factor: factor VIII binding assay for the identification of von Willebrands disease Normandy variant
    Needham, J.
    Lewis, H.
    Rangarajan, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 946 - 946
  • [32] Von Willebrand factor (VWF) assays and the diagnosis of von Willebrand disease (VWD). Who follows the guidelines?
    Jennings, I.
    Kitchen, D. P.
    Woods, T. A. L.
    Munroe-Peart, S.
    Brown, L.
    Kitchen, S.
    Walker, I. D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 54 - 54
  • [33] Von willebrand factor (VWF) assays and the diagnosis of von willebrand disease (VWD). Who follows the guidelines?
    Jennings, I
    Kitchen, D.
    Woods, T.
    Munroe-Peart, S.
    Brown, L.
    Kitchen, S.
    Walker, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 152 - 153
  • [34] The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy
    Delbrueck, Christiane
    Miesbach, Wolfgang
    ACTA HAEMATOLOGICA, 2019, 142 (02) : 71 - 78
  • [35] PHARMACOKINETIC MODELING OF THE VON WILLEBRAND FACTOR - FACTOR VIII INTERACTION IN PERIOPERATIVE VON WILLEBRAND DISEASE PATIENTS
    Bukkems, L. H.
    Heijdra, J.
    de Jager, N.
    Hazendonk, H.
    Fijnvandraat, K.
    Meijer, K.
    Eikenboom, J.
    Laros-van Gorkom, B.
    Leebeek, F.
    Cnossen, M.
    Mathot, R.
    HAEMOPHILIA, 2021, 27 : 147 - 147
  • [36] von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease
    Sidonio Jr, Robert F.
    Boban, Ana
    Dubey, Leonid
    Inati, Adlette
    Kiss, Csongor
    Boda, Zoltan
    Lissitchkov, Toshko
    Nemes, Laszlo
    Novik, Dzmitry
    Peteva, Elina
    Taher, Ali T.
    Timofeeva, Margarita Arkadevna
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Werner, Sylvia
    Knaub, Sigurd
    Khayat, Claudia Djambas
    BLOOD ADVANCES, 2024, 8 (06) : 1405 - 1414
  • [37] Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand disease
    Bukkems, Laura H.
    Heijdra, Jessica M.
    de Jager, Nico C. B.
    Hazendonk, Hendrika C. A. M.
    Fijnvandraat, Karin
    Meijer, Karina
    Eikenboom, Jeroen C. J.
    Laros-van Gorkom, Britta A. P.
    Leebeek, Frank W. G.
    Cnossen, Marjon H.
    Mathot, Ron A. A.
    BLOOD ADVANCES, 2021, 5 (05) : 1513 - 1522
  • [38] Interaction of factor VIII and von Willebrand factor and the identification of type 2 N von Willebrand disease
    Favaloro, Emmanuel J.
    THROMBOSIS RESEARCH, 2011, 127 (01) : 2 - 3
  • [39] Von Willebrand Factor (VWF) multiplex activity assay differentiation of type 1 von Willebrand Disease (VWD) and variant VWD
    Roberts, Jonathan C.
    Christopherson, Pamela A.
    Tarantino, Michael D.
    Gonzales, Sarah E.
    Morateck, Patti A.
    Perry, Crystal L.
    Flood, Veronica H.
    Abshire, Thomas C.
    Montgomery, Robert R.
    HAEMOPHILIA, 2024, 30 (01) : 161 - 168
  • [40] von Willebrand factor containing factor VIII concentrates
    Berntorp, E
    HAEMOPHILIA, 1999, 5 : 60 - 63
12345